• Forecast Value (2034): 30.96 Bn
  • CAGR (2034): 11.2%

Orthopedic Footwear Market Outlook (2024 to 2034)

The global orthopedic footwear market is estimated to reach a worth of US$ 10.67 billion in 2024 and is forecasted to expand at a CAGR of 11.2% to reach US$ 30.96 billion by 2034.

The growing number of people suffering from chronic illnesses and pain are the main growth drivers in this market, as stated in the newly published orthopedic footwear industry analysis. For those with abnormalities of the foot or ankle, orthopedic shoes are specifically made.

They lessen discomfort when walking or standing by supporting the muscles and joints. Our orthopedic footwear industry outlook indicates that foot discomfort affects at least one in four senior citizens worldwide.

The market development is greatly aided in the coming years by the growing popularity of physical activities, such as running, walking, and sports. People between the ages of 18 and 64 are advised by the World Health Organization (WHO) to participate in at least 150-300 minutes of moderate-intensity or 75-150 minutes of vigorous-intensity aerobic physical activity per week.

The public's knowledge of foot care is expanding, as is their willingness to spend more on medical supplies. The market for orthopedic footwear is expected to develop because of the several qualities that are connected with it, such as the additional width, supporting heel, and detachable insole.

The rising prevalence of plantar fasciitis is fueling growth in the worldwide market. Plantar fasciitis sufferers need to wear footwear with more padding to support their feet. Therefore, those who have plantar fasciitis also choose to wear orthopedic footwear. A 2022 NCBI research states that 83% of people with plantar fasciitis in the United States are between the ages of 25 and 65.

Report Attribute Detail
Orthopedic Footwear Market Size (2024E) US$ 10.67 Billion
Forecasted Market Value (2034F) US$ 30.96 Billion
Global Market Growth Rate (2024 to 2034) 11.2% CAGR
North America Market Value (2024E) US$ 3.66 Billion
Mexico Market Value (2034F) US$ 843.32 Million
Adult Segment Growth Rate (2024 to 2034) 11.5% CAGR
Japan Market Value (2034F) US$ 886 Million
Key Companies Profiled Aetrex Worldwide Inc.; Birkenstock Group; Caleres Inc.; Orthofeet Inc.; Drew Shoe Corporation; Apex Foot Health Inc; Anodyne LLC; DJO LLC; Ablegaitor LLC

Orthopedic shoes are a special type of shoes designed to accommodate the footwear needs of individuals possessing one of several foot disorders, medical conditions, or diseases. This type of shoes are designed for patients who are suffering from issues, such as plantar fasciitis, hammer toes, blisters, bunions, foot injuries, heel spurs, alignment issues of the musculoskeletal system, unequal leg length, diabetes, and others.

Moreover, orthopedic shoes are best for those who are suffering from foot-related disorders, such as wider toe boxes, or need orthotics or insoles for arch support. Orthopedic shoes are worn by people of all ages who suffer from poor foot mechanics as they are specifically designed to support the structure and mechanics of the foot, ankle, and leg.

In most of the countries, the cost of orthopedic footwear is reimbursed. For instance, in the United States, a medical doctor diagnoses an individual's medical issues and provides a Letter of Medical Necessity (LMN) for the individual's expense in purchasing orthopedic shoes. Insoles and arch support for orthopedic purposes are completely reimbursed in most countries.

The global market is majorly driven by a rise in the number of accidents, which is the major cause of orthopedic injury. In addition to this, an increase in the availability as well as variability of orthopedic footwear in various applications also promotes market growth.

In the context of this, about 6% of the United States population has foot injuries, bunions, and flat feet or fallen arches each year. About 60% of the United States population older than 17 are suffering from foot and ankle-related injuries, sprains, and strains of the ankle, as mentioned in the orthopedic footwear industry analysis.

According to the National Trauma Data Bank data set analysis, a total of 280,933 foot and/or ankle fractures or dislocations were identified, in major trauma hospitals in the United States, from 2007 to 2011. However, some of the factors limiting the market include ignorance of orthopedic footwear among certain patients, especially in underdeveloped countries.

The report covers an exhaustive analysis on:

  • Orthopedic Footwear Market Segments
  • Orthopedic Footwear Market Dynamics
  • Historical Actual Market Size, 2019 to 2023
  • Orthopedic Footwear Market Size & Forecast 2024 to 2034
  • Orthopedic Footwear Market Current Trends/Issues/Challenges
  • Competition & Companies Involved
  • Market Drivers And Restraints

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current, and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

Competitive Landscape

Examples of some of the key players in the global market are Aetrex Worldwide, Inc., Podartis S.r.l, Orthofeet Inc., Ablegaitor LLC., Drew Shoe Corporation, DJO, LLC, Apex Foot Health, Inc., Birkenstock Digital GmbH, ORTHOPEDIC SOLUTIONS, and others. Acquisition, mergers, strategic collaborations, and technology play vital roles in the growth of the global market, as opined in the orthopedic footwear industry outlook.

Segmentation of the Orthopedic Footwear Market Research

  • By Consumer Group :

    • Adult
    • Pediatric
  • By Distribution Channel :

    • Store Based
    • Online Store
  • By Region :

    • Northeast
    • Southeast
    • West
    • Southwest
    • Midwest

- Frequently Asked Questions -

What is responsible for the orthopedic footwear market growth?

The global orthopedic footwear market is majorly driven by a rise in the number of accidents, which is one of the major causes of orthopedic injury.

Where will the growth spearhead in the market?

North America is forecasted to witness a 13.8% CAGR over the forecast period.

Which are the top players in the market?

Some key players are Aetrex Worldwide, Inc., Podartis S.r.l, Orthofeet Inc., Ablegaitor LLC., DJO, and Drew Shoe Corporation.